Resources
The National Pharmaceutical Council (NPC) is a health policy research organization dedicated to the advancement of good evidence and science, and to fostering an environment in the United States that supports medical innovation.
Filter by:
Topic
Topic
- Accountable Care Organizations
- Alternative Payment Models
- Biopharmaceutical Innovation
- Bundled Payments
- Clinical Pathways
- Decision Frameworks
- Elements of Value
- Evidence for Decision Making
- Formulary/Benefit Design
- Formulary Development
- Good Practices for Evidence
- Health Care Quality Measures
- Health Spending
- Health Spend Management
- High-Deductible Health Plans
- Impact on Outcome & Spending
- Individual Treatment Effects & Personalized Access
- IRA Implementation
- Low-Value Care
- Pandemic Response
- Patient Cost Sharing
- Paying for Cures
- Policy & Regulatory Barriers
- Real-World Data
- Real-World Evidence
- Regulatory Barriers & Challenges
- Understanding Health Spending
- Utilization Management & Step Therapy
- Value-Based Contracts
- Value-Based Insurance Design
- Value Assessment
- Value Assessment Frameworks
- Value Assessment Methods
Resource Type
Audience
Audience
Display Only
Showing 834 Results
Why Research Methods Matter
You’ve heard the phrase "garbage in, garbage out." The same adage holds true for research: use garbage methods, and you’ll have garbage results. And with the billions of dollars in public and private…
Observational Studies May "Trouble Scientists," But They Are a Necessary Tool
ICYMI, the Wall Street Journal today ran an interesting and lengthy article, "Analytical Trend Troubles Scientists," which outlines the challenges with the design, conduct and analysis of…
The State of Comparative Effectiveness Research and the Environment for Health Care Decision Making (2012)
The National Pharmaceutical Council conducted its second annual survey of key health care stakeholders. 95 percent of respondents said that CER was "somewhat" or "very important" to them or their…
Making Informed Decisions: Assessing the Strengths and Weaknesses of Study Designs and Analytic Methods for Comparative Effectiveness Research
The purpose of this document is to provide brief descriptions of both experimental and nonexperimental study designs and methods that may be used to address CER study questions.
Pharmaceutical Technology Assessment: Perspectives From Payers
The processes and evidence used in making pharmaceutical coverage decisions vary substantially among US health plan payers. These variations during the pharmaceutical technology assessment (PTA)…
Setting Priorities for Comparative Effectiveness Research: From Assessing Public Health Benefits to Being Open With the Public
Abstract (from Health Affairs): Medicine’s current evidence base is insufficient for many of the decisions made daily by clinicians, patients, purchasers, and policy makers. The Patient-Centered…
Comparative Effectiveness Research: Do Employers Care? What Will They Do? What About Productivity?
A survey by NPC and the Benfield Group found that one of the benefits employers are looking for from CER is more information about which treatments help with productivity.
Blue Pill or Red Pill: The Limits of Comparative Effectiveness Research
Comparative effectiveness research (CER) has been heralded as a way to reduce health-care costs by determining which treatments provide the most benefit for the largest number of patients. This…
The Impact of Comparative Effectiveness Research on Health and Health Care Spending
Although health care stakeholders acknowledge that health care treatments can affect different segments of the patient population in different ways, early discussions focused on how comparative…
Employer Medication Adherence, Comorbidities, and Health Risk Impacts on Workforce Absence and Job Performance
While medication adherence is a critical element in reducing the impact of illness, employers should view it as just one of multiple components that are needed in strategic employee disease…
The Productivity Crisis in Pharmaceutical R&D
Advances in the understanding of the molecular basis of diseases have expanded the number of plausible therapeutic targets for the development of innovative agents in recent decades. However,…
The State of Comparative Effectiveness Research and the Environment for Decision-Making (2011)
Comparative effectiveness research (CER) has gained in national prominence in recent years through an infusion of federal funds and passage of the Patient Protection and Affordable Care Act (PPACA),…
Synergies at Work: Realizing the Full Value of Health Investment
According to this NPC-sponsored research, employers need a sound understanding of the value that a healthy employee population brings to their businesses. Synergies at Work: Realizing the Full Value…
The Patient-Centered Outcomes Research Institute Methodology Committee: Resource Guide
In March 2010, President Obama signed into law the Patient Protection and Affordable Care Act, broad health reform legislation that established the Patient-Centered Outcomes Research Institute (PCORI…
International Comparison of Comparative Effectiveness Research in Five Jurisdictions: Insights for the US
This article, published in the Ocotber 2010 issue of PharmacoEconomics, examines health technology assessments (HTA) in Canada, Sweden, Scotland, The Netherlands and Australia and identifies seven…
The Patient-Centered Outcomes Research Institute Resource Guide
A key provision of the Patient Protection and Affordable Care Act, the health reform legislation signed into law in March 2010, establishes the Patient Centered Outcomes Research Institute (PCORI), a…
Value in Health Special Issue: Apples and Oranges? Assessing Comparative Effectiveness and Comparative Value in the U.S. and Other Countries
This special issue of Value in Health showcases presentations made at the Apples and Oranges? Assessing Comparative Effectiveness and Comparative Value in the U.S. and Other Countries symposium held…
Value-Based Insurance Design Toolkit
Employers throughout the country are increasingly concerned with improving the health and productivity of their workforces, while maximizing the value of the health care services provided. This…
Comparative Effectiveness Research Toolkit
The establishment of the nonprofit, public-private entity, the Patient-Centered Outcomes Research Institute (PCORI), in the new health reform law has elevated the visibility and importance of…